Double dummy trials

BMJ (Online)

Volumn 343, Issue 7832, 2011, Pages 1066-

  Sedgwick, Philip ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; QUETIAPINE; RIVASTIGMINE;

AGITATION; CLINICAL RESEARCH; COGNITION; DEMENTIA; DRUG EFFICACY; DRUG SAFETY; HUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 81555201690     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d7294     Document Type: Note

References (2)

1. Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, et al. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ 2005;330:874.
2. Sedgwick P. Bias in clinical trials. BMJ 2011;342:d4176.